AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases
Background: Inborn errors of bile acid metabolism (IEBAM) cause rare but treatable genetic disorders that can present as neonatal cholestasis or neurological diseases. Without timely primary bile acid treatment, patients may develop liver failure early in life. This study aimed to analyze the types...
Saved in:
Main Authors: | Ju-Yin Chen (Author), Jia-Feng Wu (Author), Akihiko Kimura (Author), Hiroshi Nittono (Author), Bang-Yu Liou (Author), Chee-Seng Lee (Author), Ho-Sheng Chen (Author), Yu-Chun Chiu (Author), Yen-Hsuan Ni (Author), Steven Shinn-Forng Peng (Author), Wang-Tso Lee (Author), I-Jung Tsai (Author), Mei-Hwei Chang (Author), Huey-Ling Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Navigating cholestasis: identifying inborn errors of bile acid metabolism for precision diagnosis
by: Hiroshi Nittono, et al.
Published: (2024) -
Enzymes of the AKR1B and AKR1C subfamilies and uterine diseases
by: Tea eLanisnik Rizner
Published: (2012) -
Expression of the Aldo-Keto Reductases AKR1B1 and AKR1B10 in Human Cancers.
by: Brian eLaffin, et al.
Published: (2012) -
Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
by: Jakob Kljun, et al.
Published: (2022) -
Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
by: Zhiwen Fu, et al.
Published: (2022)